Note: Ingredients listed on restricted chemical lists
EC/CAS
202-966-0/101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
>25-<4001- >=5% >=5% >=5% >=0.1%
EC/CAS
227-534-9/5873-54-1
Name of the chemical
2,4’-Methylenediphenyl diisocyanate
Concentration
20-<2501- >=5% >=0.1% >=5% >=5%
EC/CAS
618-498-9/9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
10-<20
EC/CAS
219-799-4/2536-05-2
Name of the chemical
2,2’-Methylenediphenyl diisocyanate
Concentration
1-<2.501- >=5% >=0.1% >=5% >=5%
General Information
Version
1.12
Revision date
2026-05-05
Product name
BOSTIK HYTEC P510 RENORAPID
Substance name
Mixture
Icons in SDS
Company Information
company name
Bostik GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
SDS.box-EU@bostik.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H332, H334, H335, H351, H373
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Classification according to Regulation (EC) No. 1272/2008 [CLP Classification of the substance or mixture
Contains
Prepolymer, based on aromatic polyisocyanate; 4,4-Methylenediphenyl diisocyanate; o-(p-isocyanatobenzyl)phenyl isocyanate; Diphenylmethane-diisocyanate, isomers and homologues; 2,2'-methylenediphenyl diisocyanate; 4-isocyanatosulphonyltoluene tosyl isocyanate
Signal word
Danger
Hazard statements
H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 - May cause respiratory irritation. H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure.
Precautionary statements
P260 - Do not breathe mist/vapours/spray P280 - Wear protective gloves, protective clothing, eye protection and face protection P302 + P352 - IF ON SKIN: Wash with plenty of water and soap P304 + P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P337 + P313 - If eye irritation persists: Get medical advice/attention P501 - Dispose of contents/ container to an approved waste disposal plant
Special rules for supplemental label elements for certain mixtures
Persons already sensitised to diisocyanates may develop allergic reactions when using this product. Persons suffering from asthma, eczema or skin problems should avoid contact, including dermal contact, with this product. This product should not be used under conditions of poor ventilation unless a protective mask with an appropriate gas filter (i.e. type A1 according to standard EN 14387) is used. As from 24 August 2023 adequate training is required before industrial or professional use.
Additional information
This product requires tactile warnings if supplied to the general public.
2.3 Other hazards
No information available.
PBT Substances
& vPvB The components in this formulation do not meet the criteria for classification as PBT or vPvB. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity - Inhalation (Dusts/Mists) Category 4 - (H332) Skin irritation Category 2 - (H315) Eye irritation Category 2 - (H319) Respiratory sensitisation Category 1 - (H334) Skin sensitisation Category 1 - (H317) Carcinogenicity Category 2 - (H351) Specific target organ toxicity (single exposure) Category 3 - (H335) Category 3 Target organ effects: Respiratory irritation. Specific target organ toxicity (repeated exposure) Category 2 - (H373)
